Related by context. All words. (Click for frequent words.) 77 Receives Milestone Payment 77 Initiates Phase II 76 Therapeutic Competitors Companies 76 Initiates Clinical Trial 76 Completes Patient Enrollment 76 Files IND 76 Initiates Enrollment 76 Announce License Agreement 75 Receives Approvable Letter 75 Reports Preclinical Data 75 Licenses Novel 75 Initiates Clinical 74 Submits Biologics License Application 74 Initiates Phase III 74 Presents Positive 74 Receives Orphan Drug Designation 74 Develop Novel 73 Announce Merger Agreement 73 Submits NDA 73 Submits IND 73 Therapeutic Competitors companiesandmarkets.com adEgemonye 73 Begins Dosing 73 pralatrexate injection folate analogue 73 Receives Orphan Drug 72 Enrolls First 72 Presents Preclinical Data 72 Announces Licensing Agreement 72 Announce Collaboration Agreement 72 Receives CE Marking 72 SIX RO ROG 72 Initiates Dosing 72 Announces FDA Clearance 72 Exclusive License 72 R MSCRAMM 71 Files Shelf Registration Statement 71 Announces License Agreement 71 Submits Response 71 Crofelemer budesonide foam 71 Completes Enrollment 71 Announces Initiation 71 ALTROPANE R 71 Collaborators Present 71 RNAi Therapeutics 71 Successfully Completes Phase 71 Submits Supplemental 70 Receives FDA Clearance 70 Receives Patent 70 Presents Preclinical 70 JAK2 Inhibitor 70 FDA Clears 70 Amends Agreement 70 Present Preclinical Data 70 Demonstrates Significant 70 Achieves Primary Endpoint 70 Commercialize Novel 70 Valortim TM 70 Pharma Merck Serono 70 Therapeutic Antibody 70 RNAi Therapeutic 70 please visit www.metabolon.com 70 Phase 2b Clinical Trial 70 Launches Generic Version 70 Submits Application 70 SPL# Gel vaginal microbicide 69 Sign License Agreement 69 Receive Milestone Payment 69 Government Qualifying Therapeutic 69 Receives Fast Track 69 Genentech GlaxoSmithKline 69 Earns Milestone Payment 69 Awarded Patents 69 Patent Covering 69 Nasdaq XTLB 69 Sign Licensing Agreement 69 Commences Phase 69 Inc Therapeutic Competitors 69 VentiRx Pharmaceuticals 69 Files Patent Application 69 Systemic Delivery 69 IND Filing 69 Announces Tentative Approval 69 Issued Patent 69 TRANSDUR ™ 69 Immunomedics Announces 69 Presents Positive Preclinical 69 Develop Innovative 69 Files Investigational 69 Completes Dosing 69 Oral Calcitonin 69 oncolytic virus therapies 69 Shows Promise Against 69 Expands Scientific Advisory 69 Confirms Filing 69 product platforms AZX# 69 BioSante Pharmaceuticals Announces 69 KAI Pharmaceuticals 69 Antibody Drug Conjugate 69 Announce Licensing Agreement 69 Gets FDA Clearance 69 Bradmer Pharmaceuticals 69 TRANSDUR ® 68 Small Molecule 68 FDA Accepts 68 Nasdaq VNDA 68 Kelly Luethje #-#-# 68 IG HCR ;) CO 68 IRS Qualifying Therapeutic 68 Taglich Brothers Initiates Coverage 68 Vaccine Adjuvant 68 candidates Azedra TM 68 Initiate Clinical Trial 68 Completes Financing 68 Meets Primary Endpoint 68 Extends Collaboration 68 Nicotine Conjugate Vaccine 68 Small Molecule Drug 68 Visit www.BASInc.com 68 Nasdaq MNKD focuses 68 Granted Orphan Drug 68 Demonstrates Positive 68 Xcytrin R 68 Collaborators Publish 68 rxRNA 68 Idenix Novartis 68 Alvine Pharmaceuticals 68 Inc. Nasdaq OXGN 68 lead molecular radiotherapeutic 68 Drug Candidate 68 candidates Azedra 68 platform HDL Mimetic 68 Miraculins Announces 68 Develops Novel 68 visit www.genenews.com 68 AUDIO PROVIDED BY 68 Merck OSI Pharmaceuticals 68 Receives Favorable 68 Announce Initiation 68 ELADUR ™ 67 Exploit collaboration 67 Nasdaq MNKD focused 67 microRNA Therapeutics 67 Veronate R 67 Receives NASDAQ 67 Demonstrates Ability 67 Awarded Patent 67 CysDisplay R 67 Regains NASDAQ 67 visit http:/www.mannkindcorp.com 67 NOTE POSIDUR ™ 67 Expand Collaboration 67 Signs Licensing Agreement 67 FDA Approvals 67 Agonist MABA program 67 Initiates Phase 67 WeissComm Partners +#-#-#-# 67 AllPennyStocks.com Spotlights 67 DIAGNOS Announces 67 researches develops licenses 67 Identifies Potential 67 siRNA Delivery 67 Achieves ISO #:# Certification [002] 67 Receives Notice Regarding 67 TM Aganocide 67 Drug Shows Promise 67 Jumps Higher 67 Announces Issuance 67 Introduces Novel 67 OTC BB PVCT 67 OTCBB FCSC 67 Mylan Receives Approval 67 Sinks Lower 67 4SC AG ISIN DE# 67 personalized cellular immunotherapy 67 visit http:/www.neogenomics.org 67 Vitrasert R 67 markets HP Acthar 67 Milestone Payment 67 Immunotherapeutic 67 Initiates Clinical Trials 67 Antisense Drug 67 proprietary intranasal insulin 67 pharmacogenomic translational research 67 Biomarker Study 67 Regains Compliance With 67 Juvaris BioTherapeutics 67 Settle Patent Litigation 67 PROGENSA R 67 molecular imaging radiopharmaceutical 67 Genentech sanofi aventis 67 Receives Tentative FDA 67 Selective Electrochemical Tumor Ablation 67 Enters Into Collaboration 67 OTCBB NRGX 67 Confirms Efficacy 67 Voluntarily Withdraw 67 targeted anticancer biopharmaceuticals 67 Novel Antibody 67 Completes Recapitalization 67 Phase 2b Trial 67 Board Authorizes 67 Successfully Completes Acquisition 67 Cardioxyl Pharmaceuticals 67 DARA logo 67 FOLOTYN ® 67 Patient Enrollment 67 Signs Option Agreement 67 Taro Receives 67 Neutrolin ® 67 http:/www.pharmacopeia.com 67 HuCAL PLATINUM R 67 Achieves Milestone 67 OTCBB PYTO 67 Therapeutic Competitors Report 66 Staphylococcus aureus Immune Globulin 66 Initiates Phase 2b 66 Boehringer Ingelheim MedImmune 66 OTCQX QRXPY 66 Abstract Accepted 66 Reports Inducement Grants 66 BIOTECHNOLOGY SOURCE 66 Aradigm Logo 66 Provides Update Regarding 66 Licenses Patents 66 molecular therapeutics immunotherapies 66 Genotyping Test 66 MONSTERSTOX.COM Monsterstox.com 66 Fast Track Status 66 sanofi aventis Bayer Schering 66 Submits Investigational 66 Announces Stock Buyback 66 Welcomes Analyst Initiation 66 Announces Poster Presentations 66 Therapeutic Competitors 66 Hematology Molecular Pathology 66 Regains Full 66 Nasal Powder 66 Settle Patent Dispute 66 Genisphere 66 Announces Favorable 66 OTCBB QTXB 66 Captisol ® 66 Nasdaq HALO 66 BayStreet.ca Research Alert 66 Announce Collaboration 66 Investigational Treatment 66 anti botulism antibody 66 ASE SVA 66 Investigational Oral 66 Inc. Nasdaq IMGN 66 Announces Granting 66 Receives Tentative Approval 66 OTCQB CTIX 66 XL# anticancer compounds 66 Reacquires 66 candidate deforolimus 66 Secures Funding 66 Completes Reverse Merger 66 Receives Complete Response 66 NASDAQ MNKD focuses 66 Receives Conditional 66 Receives Funding 66 OTCBB IBPM 66 OTCBB URGP specialty 66 novel therapeutic antibodies 66 Psoriasis Drug 66 TRACON Pharmaceuticals 66 NanoInk logo 66 Announces Successful Completion 66 Scripps Genomic Medicine 66 ALN PCS 66 Jointly Announce 66 NicVAX TM 66 GlaxoSmithKline MedImmune 66 Pruvel TM 66 please visit http:/www.vandapharma.com 66 Akebia Therapeutics 66 Restructures Operations 66 Namenda Memantine HCl 66 Teva Provides Update 66 Cephalon GlaxoSmithKline 66 Protein Biomarker 66 Shows Statistically Significant 66 successfully commercialize Iluvien 66 Oral Solution OSMOPREP 66 Telik logo TELINTRA 66 Thewallstreetleader.com Profiles 66 Completes Patient Enrolment 65 Cenomed 65 Nasdaq AVNC 65 Nicotine Vaccine 65 Announce Expiration 65 Catalyst Biosciences 65 pipeline ImmunoGen collaborators 65 Inc. www.micromet inc.com 65 OTCBB IMUC 65 GVAX ® 65 please visit http:/www.sunesis.com 65 Begins Shipment 65 Files Provisional 65 HuMax TAC 65 Ltd. OTCBB IMUC 65 SBIR Grant 65 Secures Patent 65 Therapeutic Discovery 65 OTCBB TDLP 65 Sirna Therapeutics StrataCom 65 Announces Positive 65 Novartis Novo Nordisk 65 Colaris Colaris AP 65 Announces Non Brokered 65 Completes Tender Offer 65 Closes Financing 65 Ercole Biotech 65 programs visit http:/www.bionovo.com 65 Company website www.anormed.com 65 Announce Early Termination 65 First Patient Enrolled 65 include ColorectAlert TM 65 EMD Biosciences Inc. 65 RealPennies.com RealPennies.com 65 NYSE Amex PBTH 65 Kinase Inhibitor 65 Receives CE 65 BY WILLA J. 65 Regains Compliance 65 Locked Nucleic Acid 65 Frankfurt XMP 65 novel orally inhaled 65 Reveals Positive 65 Prostate Cancer Vaccine 65 Anti Angiogenesis 65 HuCAL PLATINUM ® CysDisplay 65 developing ACAPODENE 65 delivery polymer matrix 65 Prodarsan R 65 Announce Licensing 65 name Biospherics 65 Uracyst R Test 65 Successfully Completes Tender Offer 65 PRN FDA Approves 65 label Lipofen R 65 RainStorm 65 Novartis Organon 65 please visit http:/www.atherogenics.com 65 Completes Initial 65 Maven Semantic 65 International www.iscointl.com 65 Paris IPN Euronext 65 subsidiaries visit http:/www.apricusbio.com 65 Receives Notification 65 visit http:/www.martek.com 65 Obtains License 65 Bifunctional Muscarinic Antagonist Beta2 65 Receives ISO #:# [002] 65 Study Demonstrates 65 Tomorrow Cures 65 Generx ® 65 Receives Stockholder Approval 65 vapreotide acetate 65 Phase IIb Clinical Trial 65 Reports Receipt 65 Enters Into Licensing Agreement 65 AMEX KAL 65 Demonstrates Statistically Significant 65 novel proprietary KL4 65 Secures Additional 65 Shows Promise 65 Restructures Debt 65 ASX BLT 65 Tibotec BVBA 65 Secures Financing 65 Dyax logo 65 CORTOSS R 65 symbol AVXL 65 S. Arzerra 65 humanized therapeutic 65 MEK Inhibitor 65 Naglazyme R 65 Commercialize 65 targeted radiotherapeutic 65 ARRY # 65 Shareholders Approve Acquisition 65 Scientists Uncover 65 Announces Presentation 65 Obtains Exclusive License 65 Saegis Pharmaceuticals 65 Preclinical Data 65 Introduces Breakthrough 65 Inc. OTCBB SPRX 65 MSCRAMM ® 65 First Patient Treated 65 Initiate Phase 65 proprietary capillary aerosolization 65 Announce Definitive Agreement 65 introduced NEUGENE 65 Announces Dismissal 65 Nasdaq ONXX 65 Spray Venture Partners 65 Private Placement Closed 65 Using Dip Pen 65 Develop Next Generation 65 Intravenous Human 65 Lupus Drug 65 Commences Phase III 65 OTCBB HDVY 65 telomerase therapeutic 65 Clinical Trial Results 65 Subsidiary Enters 65 Genentech Wyeth Pharmaceuticals 65 OTCBB HNAB 65 developing ostarine selective 65 Prolongs Survival 65 Awarded GSA 65 PerkinElmer Acquires 65 Vitamin D analogue 65 Shows Promising 65 Protalex Inc. 65 NASDAQ ENMD 64 Migraine Drug 64 Q2 Loss Narrows 64 2hours #mins #.#secs M 64 Bristol Myers Squibb Celgene 64 MBRX 64 product candidate Lpathomab 64 apricitabine ATC 64 Consummates 64 Aeolus Pharmaceuticals Announces 64 Merck Serono Nycomed 64 Reports Positive 64 Meritage Pharma 64 -Pahuta 64 Identifies Key 64 Finalizes Acquisition 64 Exherin 64 Receives Unsolicited 64 XNOM 64 Nereus Pharmaceuticals 64 Significantly Improves 64 markets COLAZAL 64 Accelerate Commercialization 64 Protease Inhibitor 64 Provides Updates 64 Investigational Compound 64 Unanimously Recommends Approval 64 Anti Tumor 64 Microwave Ablation System 64 Vaccine Protects Against 64 molecular chaperone regulation 64 Attracting Bullish Investors 64 AVI BioPharma Announces 64 Patent Issued 64 Inc. http:/www.endocare.com 64 Finalizes Purchase 64 Ebola Vaccine 64 DNA methyltransferase inhibitors 64 NASDAQ DSCO 64 Ocular Disease 64 recombinant biopharmaceutical 64 Drug Fails 64 developing biomedical countermeasures 64 OTCStockExchange.com Stock Alert 64 include Altastaph TM 64 SCIB1 64 Settles Patent Dispute 64 Phase 2a Trial 64 Wins Patent Infringement 64 FDA Okays 64 Metabolic Disease 64 pentadentate logo R 64 manufactures minimally invasive 64 Terminate Merger Agreement 64 Closes Second Tranche 64 Settles Patent Litigation 64 Announces Discontinuation 64 INDICATED LOWER 64 Hsp# Inhibitor 64 Therapeutic Vaccine 64 Enters Into Exclusive 64 Lung Cancer Drug 64 Supernus Pharmaceuticals 64 LIFE TECH 64 Protein Expression 64 Essence Ultra LifePak 64 NASDAQ ADLR 64 VIVUS Announces 64 Clinical Study Shows 64 Closes Merger 64 enhanced skin permeation 64 Inc. ProMetic www.prometic.com 64 ZFP Therapeutics 64 Pathway Diagnostics 64 Protein Polymer Technologies 64 Unigene nasal calcitonin 64 Flagship Product 64 topically applied SEPA 64 Nanophase Announces 64 nano particle tumor suppressor 64 var arrMeta = 64 Novel Therapeutic 64 Announces Shareholder Approval 64 Nasdaq AEGR 64 developing Surfactant Replacement 64 Combination REOLYSIN R 64 Announces Additions 64 5 lipoxygenase activating 64 product TNFerade TM 64 Therapeutic Efficacy 64 AAG geldanamycin analog 64 Exercises Option 64 NDA Submission 64 Selects BoardVantage 64 Phase III Clinical Trial 64 allosteric modulator PAM 64 Demonstrates Potential 64 Anti CD# Antibody 64 Receives Positive 64 Settles Litigation 64 Inc. NASDAQ QLTI 64 GNSZ 64 Prolexys 64 Novel Oral 64 Tyrosine Kinase Inhibitor 64 recurrent metastatic ovarian cancer 64 Bullish Average Crossover 64 Enters Into License Agreement 64 otcstockexchange.com 64 Molecular Diagnostic 64 OMAPRO ™ 64 Report companiesandmarkets.com adds 64 progressive metastatic prostate 64 NASH Huntington 64 submitted supplemental Biologics 64 Inc. Nasdaq VIAP 64 Transdel Pharmaceuticals Inc. 64 IMPACS R 64 AVANIR Pharmaceuticals Announces 64 Biologics Manufacturing 64 NeutroPhase TM 64 Tuberculosis Vaccine 64 Announces Termination 64 ATRA IV 64 Nasdaq EPCT 64 Inc. OTCBB MBCI 64 acetonide FA 64 Phase 1b Clinical Trial 64 GTC recombinant form 64 Test Detects 64 MOVIPREP R 64 Receives SFDA Approval 64 cladribine Cladribine Tablets 64 Crucell Announce 64 Personalized Immunotherapy 64 Inc. www.chemaphor.com uses 64 Biodefense Division 64 Small Molecules 64 WEB OF SCIENCE 64 Civacir TM Hepatitis C 64 ELADUR TM 64 Fragment Based 64 InterfeRx TM 64 BRILINTA 63 Signs License Agreement 63 Arno Therapeutics 63 http:/www.sunesis.com 63 exclusive sublicense 63 Antibody Discovery 63 Lexicon Genetics Incorporated 63 Files Preliminary Prospectus 63 Earns Certification 63 Potassium Chloride Sodium Ascorbate 63 Nasdaq IMGN 63 HDVY 63 By JAMAAL ABDUL 63 IMRX 63 Mutually Agree 63 Achieves Milestones 63 Upcoming Deadline 63 FDA APPROVES 63 NPC 1C 63 Cardium Therapeutics TM 63 hyaluronidase enzyme 63 KL4 Surfactant 63 evaluating picoplatin 63 Oracea TM 63 Discovery Project QTDP 63 Announces Consummation 63 Nasdaq ENMD 63 non nucleoside inhibitor 63 Vascular Disrupting Agent 63 Syntonix Pharmaceuticals 63 non porcine pancreatic 63 Disease IBD 63 Tezampanel 63 First Patient Dosed 63 Kosan dependence 63 developing Bicifadine serotonin 63 cosmetic cosmeceutical products 63 Xytis 63 Proves Successful 63 oral prodrug 63 includes TOLAMBA TM 63 Closes Previously Announced 63 Kuvan R 63 Nasdaq RXII 63 Aduro BioTech 63 Shrink OTCBB INKN 63 miRagen Therapeutics 63 highly purified pasteurized 63 equine osteoarthritis marketed 63 MKC# MKC# PP 63 TURNING INSIGHTS INTO HOPE 63 Successfully Concludes 63 NYSE Amex YMI 63 NASDAQ PPHM clinical 63 QMDT 63 Inc. OTCBB ECTE 63 mesylate tablets approved 63 Announces Dosing 63 Introduce Next Generation 63 commercializing oxidized glutathione 63 Confirms Significant 63 Source Victhom Human 63 Inovio Pharmaceuticals 63 NASDAQ AVEO biopharmaceutical 63 Pulmo BioTech Inc. 63 candidate XP# 63 FY# Loss Widens 63 RxKinetix 63 Retains CCG Investor Relations 63 Closes Private Placement 63 POSIDUR TM ELADUR TM 63 Medical Countermeasure 63 Aptamer 63 AnaSpec Introduces 63 Increases Share Repurchase 63 Avian Influenza Vaccine 63 Achieves Significant 63 Arriva Pharmaceuticals 63 Demonstrates Efficacy 63 Files Patent 63 proprietary PEGylation 63 NasdaqSC ASTM 63 Receives Clearance 63 Diagnostic Tests 63 Treatment Reduces 63 molecular imaging radiopharmaceuticals 63 Study Validates 63 using VIAdel TM 63 Receives Regulatory 63 M.D. Joins 63 Helps Predict 63 Regains Nasdaq 63 Receives Confirmation 63 agonistic human 63 Enhanze 63 OTCBB CHKT 63 Vitrasert ® 63 Buy Privately Held 63 Therapeutic Antibodies 63 Initiate Phase III 63 delivers fluocinolone acetonide FA 63 USP Tablets PEPCID 63 NASDAQ DIGE 63 Pafuramidine 63 Obtains CE Mark 63 LES EXPLOSIFS NORDEX LTEE 63 dedicated CHAT ROOM 63 Improves Survival 63 http:/www.appliedbiosystems.com/ 63 Indevus Pharma 63 www.combinatorx.com 63 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 63 Successfully Closes 63 palonosetron hydrochloride Injection Dacogen 63 Invites Investors 63 please visit http:/www.supergen.com 63 Bristol Myers Squibb sanofi 63 Begin Clinical Trials 63 Universal Pandemic Influenza 63 DRRX 63 Enters Into Agreement 63 Successfully Treated 63 Engages CHF Investor Relations 63 please visit www.medicinova.com 63 TSX CTI 63 Inc. OTCBB APNS 63 Announces Formation 63 PharmaNova 63 Study Evaluating 63 GeneThera Inc. 63 markets XIFAXAN ® 63 Quark Biotech 63 novel MetAP 2 63 Agios Pharmaceuticals 63 NASDAQ MIPI 63 DepoCyt ® Abelcet ® 63 Completes Private Placement 63 OTCBB ILNS 63 Islet Transplantation 63 Molecular Diagnostic Test 63 UGNE 63 VIA Pharmaceuticals 63 DayTradersDigest.com Profiles 63 Collaborates With 63 Genaera Corporation 63 Nasdaq AMAG 63 Isolagen specializes 63 Idera Pharmaceuticals 63 Corixa Corporation 63 OTCBB PWRM.OB 63 Alnylam Nasdaq ALNY 63 Nasdaq PARD 63 CD# CEA 63 Marcus Gronholm BP 63 ZyStor Therapeutics Inc. 63 Bayhill Therapeutics 63 Antigen Specific 63 PF # [002] 63 Inc. NASDAQ SIRT 63 personalized dendritic 63 Updates Status 63 TSX Delisting Review 63 FoldRx Pharmaceuticals Inc. 63 Geokinetics Announces 63 Unveils Expanded 63 www.palatin.com 63 Oral Suspension USP 63 ST PHOTO CAROLINE 63 Terminates Merger Agreement 63 Announces Cancellation 63 candidate MyVax 63 Terminates Agreement 63 Skymark Research Initiates Independent 63 Develops Breakthrough 63 HDL Mimetic Peptide 63 LungAlert TM 63 NewsBite Downgrade Puts Pressure 63 Successfully Completed 63 Rigel R# 63 Qualified Therapeutic Discovery 63 developing Zerenex ferric 63 Nasdaq Deficiency Notice 63 Erica Elchin #-#-# 63 ZFNs clinical trials 63 Demonstrates Sustained 63 Founding Scientist 63 Crucell NV NYSE Euronext 63 Predictive medicine 63 IgG1 monoclonal antibody 63 commercialize CorMedix drug 63 Monoclonal Antibody 63 Further Validates 63 ACAPODENE R 63 lexidronam injection 63 BUPHENYL R 63 Patents Covering 63 Epilepsy Drug 63 Bearish Speculation 63 derivatives Radilex TM 63 Pharmacogenomic 63 STERIS Corporation Announces 63 Appoints Seasoned 63 Aestus Therapeutics 63 COMPLETES ACQUISITION OF 63 Announce Successful Completion 63 Expanded Indication 63 Receives Approval From 63 Empatic ™ 63 KAI Pharmaceuticals Inc. 63 Preclinical Study 63 Unveils Groundbreaking 63 Nasdaq IDIX 63 Pruvel ™ 63 THERAPEUTICS 63 Strengthens Balance Sheet 63 TELINTRA R 63 Nasdaq NPSP 63 Extend Collaboration 63 Terminates Contract 63 NYSE Amex AEN 62 AGY Therapeutics 62 Announces Postponement 62 Translational Biology 62 Molecular Profiling 62 Hainan Helpson Medical 62 SHORT ON CHEDDAR 62 Launches Next Generation 62 Nanoemulsion 62 Authorizes Share Repurchase 62 Boehringer Ingelheim Bristol Myers 62 Canaccord Genuity Reiterates Buy 62 Adjuvanted 62 Potelligent Technology 62 Lipid Polymer Micelle LPM 62 Neurome 62 Momenta Pharmaceuticals MNTA 62 Generic Version 62 Coverage Initiated 62 proprietary intravenous formulation 62 HuCAL GOLD R 62 Synerx Pharma 62 visit www.targanta.com 62 Smartstox.com Spotlights 62 NYSE Amex BTX 62 HYVISC ® treatment 62 Additionally Soligenix 62 candidate Lovaxin C 62 NASDAQ SPEX 62 ThermoDox ® clinical 62 InterfeRx 62 Horizant ™ 62 Liprotamase 62 Sirion Therapeutics 62 SABER ™ 62 TapImmune Inc. 62 Prism Pharmaceuticals 62 http:/www.unigene.com 62 rusalatide acetate 62 AMEX RGN 62 OTCBB VCRT 62 Confirms Receipt 62 GendeLLindheim BioCom Partners 62 HPV cervical dysplasia 62 visit http:/www.PAREXEL.com 62 Stockholders Approve Merger 62 Nanotechnology Characterization Laboratory 62 oral dihydropyrimidine dehydrogenase DPD 62 Endures Analyst Downgrade 62 novel peptides 62 IND Application 62 Effectively Treats 62 Inflammatory Disease 62 candidate TNFerade biologic 62 Alfacell proprietary ribonuclease 62 Through Glycoscience R 62 Crit Rev 62 Nasdaq PGNX 62 Avian Transgenic Technology 62 addressing idiopathic pulmonary 62 transthyretin mediated amyloidosis ATTR 62 kidney urologic 62 Continues Commitment 62 AVXL 62 Transgenomic Pharmacogenomics Services 62 -gamma secretase modulator 62 TKB# 62 Prochymal TM 62 Viamet Pharmaceuticals 62 Inc. OTCBB CYKN 62 Receives Favorable Ruling 62 5 HT3 antagonist 62 OTCBB IMNR 62 CYT# potent vascular disrupting 62 Nasdaq SGEN 62 NASDAQ CRXL 62 Novel Vaccine 62 Announces Effective Date 62 Completes Merger 62 Postdoctoral Position 62 USP Tablets VISICOL ® 62 Receives Accreditation 62 Project QTDP 62 advanced compound INCB# 62 website www.celsion.com 62 Equity Funds Declare 62 Broadens Its 62 Novel Antibiotic 62 Announces Definitive Agreement 62 Gets Bearish Confirmation 62 Nasdaq LEXG 62 Files Patent Infringement 62 mertansine 62 OTCBB CTIX 62 Ichor Medical Systems 62 Nasdaq DIGE News 62 Announces Divestiture 62 PROLOR Biotech Inc. 62 HCV Protease Inhibitor 62 Partnering Agreements 62 RNA Therapeutics 62 Inc. www.sanuwave.com 62 FDA Clearance 62 Prednisporin 62 NYSE Amex RNN 62 Recombinant Protein 62 Companion Diagnostic 62 Inc. OTCBB VIVK 62 Commence Phase 62 PRAECIS PHARMACEUTICALS INCORPORATED 62 Phase IIb Trial 62 POTELLIGENT R 62 Approves Share Repurchase 62 Budesonide foam crofelemer 62 Pathogen Detection 62 Registration Statement Declared Effective 62 Nasdaq BMRN 62 Rheumatoid Arthritis Drug 62 Arch Biopartners 62 Regenerative Cell 62 Unveils Latest Version 62 Completes Previously Announced 62 FDA Approves 62 specific ZFP Nucleases 62 Pharmaceuticals Initiates 62 RGIN 62 AMEX NVD specialty 62 Dose Ranging Study 62 Updates Shareholders 62 PHRM 62 Expression Genetics 62 Vysis 62 OTCBB CVBT 62 Curon Control 62 Inc. AMEX YMI 62 TRIOLEX HE# APOPTONE HE# 62 Key Milestones 62 R Saizen R 62 Milestone Payment From 62 Announces Reverse Split 62 TFChem licenses 62 Ltd Therapeutic Competitors 62 Artificial Pancreas 62 comprise Alnylam RNAi 62 Ohr Pharmaceutical Inc. 62 Joins OTCQX 62 QuantRx Biomedical Corporation 62 telomerase inhibitor drug 62 Diabetic Foot Ulcer 62 HDL Selective Delipidation 62 OTCBB AGNM 62 MEDAREX 62 DG# compounds targeting 62 Inc. Nasdaq MITI 62 Shows Efficacy 62 ZFN TM 62 CoTherix logo 62 ALN HPN 62 Bullish Technical Alert 62 Announce Distributions 62 Trial Evaluating 62 Integrated Preclinical 62 ArQule Kinase Inhibitor Platform 62 Secures Long Term 62 OTC BB PVCT http:/www.pvct.com 62 Nasdaq HALO biopharmaceutical 62 TB Vaccine 62 commercializing anti infective 62 minimally invasive vascular suturing 62 www.nanoviricides.com 62 Inflammatory Arthritis 62 Sciences ABthrax Albuferon 62 AKIP ™ 62 Tumor Targeting 62 Researchers Identify 62 Cephalon GlaxoSmithKline Schering Plough 62 TSX VENTURE MOM 62 Compugen NASDAQ CGEN 62 Regado Biosciences 62 Shai Novik President 62 Fibrocell Science Inc. 62 Luveris R Ovidrel R 62 Hematological Malignancies 62 Microfluidic Systems 62 Gout Drug 62 Corp. AMEX CVM 62 Patent Broadly Covering 62 gastro intestinal inflammation 62 Vaccine Shows Promise 62 Nasdaq DVAX 62 AQUA ® 62 Hydra Biosciences 62 signal detection CTSD 62 particularly SANCTURA XR 62 Enzon Pharmaceuticals Inc 62 read Palintologist 62 OTCBB HXBM developer 62 Anticancer Drug 62 Launches Unique 62 purinergic receptors P#X# 62 Provides Clarification 62 Schizophrenia Drug 62 Medisorb ® 62 Trellis Bioscience 62 www.vivus.com 62 Advancis Pharmaceutical Corporation 62 RECOTHROM ® 62 Pandemic Influenza Vaccine 62 Aloprim TM allopurinol sodium 62 Announce Commencement 62 Perflubutane Polymer Microspheres 62 IXSBF 62 www.inhibitex.com 62 ALN TTR 62 aldehyde dehydrogenase ALDH2 deficiency 62 Benzinga Volume Movers 62 Regenerative Cells 62 PORxin TM platforms 62 Ridaforolimus 62 Innovive Pharmaceuticals